Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,983
Total Claims
$1.5M
Drug Cost
766
Beneficiaries
$1,959
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-81%
Opioid rate vs peers
0.4% vs 2.2% avg
+39%
Cost per patient vs peers
$1,959 vs $1,411 avg
+54%
Brand preference vs peers
16.4% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.4%
Opioid Rate
96
Opioid Claims
$28K
Opioid Cost
27.1%
Long-Acting Rate
Brand vs Generic
Brand: 3,738 claims · $1.1M
Generic: 19,091 claims · $426K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 752 | $178K |
| Pimavanserin Tartrate | 70 | $119K |
| Empagliflozin | 236 | $59K |
| Rivaroxaban | 188 | $45K |
| Linagliptin | 160 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 89 | $28K |
| Oxycodone Hcl | 13 | $26K |
| Mirabegron | 157 | $26K |
| Dulaglutide | 44 | $24K |
| Deutetrabenazine | 11 | $24K |
| Rifaximin | 24 | $22K |
| Insulin Glargine,hum.Rec.Anlog | 175 | $22K |
| Sitagliptin Phosphate | 80 | $20K |
| Rsv Vacc, Pref A And Pref B/Pf | 61 | $19K |
| Divalproex Sodium | 323 | $19K |
Prescribing Profile
Patient Profile
79
Avg Age
62%
Female
2.66
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About